Abstract:BACKGROUND: We have developed a formulation of polycationic liposomes that has been shown to be non-toxic, highly stable in the bloodsteam, and very effective in liver gene transfer in mice (Gene Therapy 2003; 10:180–187). Extracellular superoxide dismutase (EC-SOD) inhibits the generation of superoxide anions in the interstitial space of tissues, and may play a role in minimizing oxidative stress in liver injury. The aim of the present study is to investigate whether our polycationic liposome-mediated human EC-SOD gene delivery will protect against lipopolysaccharide (LPS)-induced liver toxicity in D-galactosamine (GalN)-sensitized mice. METHODS: Polycationic liposomes were generated from polycationic lipid (PCL) and cholesterol (Chol). Lipoplexes were formed by complexing liposomes with control plasmid (pEGFP-C1) or EC-SOD plasmid (pEGFP-C1-ECSOD) before use. Mice were injected with thyroid hormone (T3, 4 mg/kg, s.c.) two days before lipoplexes were injected via the portal vein. One day following lipoplex injection, mice were treated with GalN (500 mg/kg, i.p.) plus LPS (25 mg/kg, i.p.). Serum alanine aminotransferase (ALT), SOD activity, liver histology, glutathione (GSH) content and lipid peroxidation were evaluated one day after GalN/LPS exposure. Human EC-SOD gene expression in mouse liver tissue was determined by quantitative RT-PCR two days after lipoplex injection. RESULTS: somes and the control lipoplexes were stable in their size for three months at 4°C. Injection of T3, PCL-Chol liposomes or control lipoplexes did not cause a significant change in serum ALT levels. Real time quantitative RT-PCR analysis showed that human EC-SOD mRNA levels in mouse liver tissue in EC-SOD lipoplex-injected group were 55-fold higher than saline, liposome or control lipoplex controls when mouse -actin was employed as a house-keeping control gene. Serum ALT levels in animals receiving portal vein injections of EC-SOD lipoplexes plus GalN/LPS exposure were much lower than in those receiving normal saline, liposomes alone, or control lipoplexes plus GalN/LPS exposure (62583 vs. 150865, 153194, 1880520 units/ml, p<0.01). Liver histology showed much less hepatocyte death in EC-SOD lipoplex-treated group than liposome- or control lipoplex-treated groups. Serum SOD activity in animals receiving injection of EC-SOD lipoplexes were higher than in those treated with liposomes only, or control lipoplexes (28.8 3.3 vs. 15.2 0.9, 17.4 3.4 units/ml, p<0.05). Liver GSH content in animals receiving EC-SOD lipoplex injection was preserved with less lipid peroxidation, as indicated by a lower level of malondialdehyde content. CONCLUSIONS: liposome-mediated EC-SOD gene delivery leads to the marked transgene expression, and attenuates acute liver injury due to reduced oxidative stress in GalN/LPS-exposed mice. To our knowledge, this is a first report which demonstrates that polycationic liposome-mediated EC-SOD gene delivery to the liver represents a potential therapy for hepatotoxin-induced liver injury.

Study on Polyethylene Glycol Modified Superoxide Dismutase

Preparation of microspheres of superoxide dismutase and their activities

Chemical Modification of Superoxide Dismutase with Bovine Sermn Albumin

Chemical Modification of Activated Polyethylene Glycol to Lysozyme and Granulocyte Colony-Stimulating Factor

Characterization and Stability Investigation of Cu,Zn-superoxide Dismutase Covalently Modified by Low Molecular Weight Heparin

Coupled procedure of SOD purification and modification

Distribution of Superoxide Dismutase Liposome in Mouse and Its Effect on the Lipid Peroxide

Preparation of Superoxide Dismutase Derivative with Polyethylene Glycol Mono Methyl Ether and Its Labeling with Radioactive I125

Chemical Modification of Superoxide Dismutase by Low Molecular Weight Heparin and Their Physical and Chemical Properties

Pharmacokinetic Analysis of in Vivo Disposition of Heparin-Superoxide Dismutase

Liposome-mediated Extracellular Superoxide Dismutase Gene Delivery Protects Against Acute Liver Injury in Mice.

[Pharmacokinetics and Distribution of Superoxide Dismutase Liposomes in Rats].

Polymer Conjugation to Cu,Zn-SOD and Suppression of Hydroxyl Radical Generation on Exposure to H2O2: Improved Stability of SOD in Vitro and in Vivo

Therapeutic Uptake of Oral Administrated Cu/Zn-Superoxide Dismutase Fused with Protein Transduction Domain

Augmented Inhibitory Effect of Superoxide Dismutase on Superoxide Anion Release from Macrophages by Chemical Modification with Polysaccharide and Attenuation Effects on Radiation-Induced Inflammatory Cytokine Expression in Vitro

677. Polycationic Liposome-Mediated Extracellular Superoxide Dismutase Gene Delivery Leads to High Levels of the Transgene Expression and Prevents Acute Liver Injury in Mice

Stability Profiles and Therapeutic Effect of Cu/Zn Superoxide Dismutase Chemically Coupled to O-Quaternary Chitosan Derivatives Against Dextran Sodium Sulfate-Induced Colitis

Chemical Modification of Superoxide Dismutase with N-trymethyl Chitosan

Microwave Assisted Extraction of Superoxide Dismutase from Pig Blood

Study of Antiradiation Effect of Human Recombinant Copper,zine-Superoxide Dismutase on Mice

Site-specific chemical modification of human serum albumin with polyethylene glycol prolongs half-life and improves intravascular retention in mice.